Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-SERPINB2 (1-415) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:200-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
SERPINB2 |
Gene ID: |
5055 |
Uniprot ID: |
PAI2_HUMAN |
Immunogen Region: |
1-415 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-415 of human SERPINB2 (NP_002566.1). |
Immunogen Sequence: |
MEDLCVANTLFALNLFKHLA KASPTQNLFLSPWSISSTMA MVYMGSRGSTEDQMAKVLQF NEVGANAVTPMTPENFTSCG FMQQIQKGSYPDAILQAQAA DKIHSSFRSLSSAINASTGN YLLESVNKLFGEKSASFREE YIRLCQKYYSSEPQAVDFLE CAEEARKKINSWVKTQTKGK IPNLLPEGSVDGDTRMVLVN AVYFKGKWKTPFEKKLNGLY PFRVNSAQRTPVQMMYLRE |
Post Translational Modifications | The signal sequence is not cleaved. |
Function | Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1. |
Protein Name | Plasminogen Activator Inhibitor 2Pai-2Monocyte Arg-SerpinPlacental Plasminogen Activator InhibitorSerpin B2Urokinase Inhibitor |
Database Links | Reactome: R-HSA-75205Reactome: R-HSA-8950505 |
Cellular Localisation | CytoplasmSecretedExtracellular Space |
Alternative Antibody Names | Anti-Plasminogen Activator Inhibitor 2 antibodyAnti-Pai-2 antibodyAnti-Monocyte Arg-Serpin antibodyAnti-Placental Plasminogen Activator Inhibitor antibodyAnti-Serpin B2 antibodyAnti-Urokinase Inhibitor antibodyAnti-SERPINB2 antibodyAnti-PAI2 antibodyAnti-PLANH2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance